Kingswood Wealth Advisors LLC bought a new stake in BlackRock Health Sciences Term Trust (NYSE:BMEZ – Free Report) in the fourth quarter, HoldingsChannel.com reports. The institutional investor bought 29,134 shares of the company’s stock, valued at approximately $420,000.
A number of other hedge funds and other institutional investors also recently made changes to their positions in BMEZ. Sanctuary Advisors LLC bought a new position in BlackRock Health Sciences Term Trust in the second quarter valued at about $3,179,000. Brown Lisle Cummings Inc. boosted its holdings in BlackRock Health Sciences Term Trust by 6.2% in the third quarter. Brown Lisle Cummings Inc. now owns 36,513 shares of the company’s stock valued at $578,000 after acquiring an additional 2,128 shares during the last quarter. Dakota Wealth Management boosted its holdings in BlackRock Health Sciences Term Trust by 23.4% in the third quarter. Dakota Wealth Management now owns 22,509 shares of the company’s stock valued at $357,000 after acquiring an additional 4,267 shares during the last quarter. Oppenheimer & Co. Inc. boosted its holdings in BlackRock Health Sciences Term Trust by 0.6% in the third quarter. Oppenheimer & Co. Inc. now owns 204,354 shares of the company’s stock valued at $3,237,000 after acquiring an additional 1,153 shares during the last quarter. Finally, Penserra Capital Management LLC bought a new position in BlackRock Health Sciences Term Trust in the third quarter valued at about $15,390,000.
BlackRock Health Sciences Term Trust Trading Up 1.3 %
BlackRock Health Sciences Term Trust stock opened at $16.60 on Friday. The business’s 50-day simple moving average is $15.40 and its 200 day simple moving average is $15.64. BlackRock Health Sciences Term Trust has a 12-month low of $14.27 and a 12-month high of $16.65.
BlackRock Health Sciences Term Trust Announces Dividend
About BlackRock Health Sciences Term Trust
BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.
Read More
- Five stocks we like better than BlackRock Health Sciences Term Trust
- What is an Earnings Surprise?
- How Growth Investors Find High-Growth Stocks and Maximize Returns
- Where Do I Find 52-Week Highs and Lows?
- Meta’s AI & Smart Glasses Could Drive 20%+ Upside in 2025
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- NVIDIA’s Slide Continues: Can Retail Investors Stop the Fall?
Want to see what other hedge funds are holding BMEZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock Health Sciences Term Trust (NYSE:BMEZ – Free Report).
Receive News & Ratings for BlackRock Health Sciences Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.